Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2015 May 13;10(5):e0125588.
doi: 10.1371/journal.pone.0125588. eCollection 2015.

The Day-Hospital of the University Hospital, Bobo Dioulasso: An Example of Optimized HIV Management in Southern Burkina Faso

Julie Chas  1 , Arsène Hema  2 , Laurence Slama  1 , Nongondo Firmin Kabore  2 , François-Xavier Lescure  3 , Camille Fontaine  4 , Gilles Pialoux  5 , Adrien Sawadogo  2
Affiliations
Observational Study

The Day-Hospital of the University Hospital, Bobo Dioulasso: An Example of Optimized HIV Management in Southern Burkina Faso

Julie Chas et al. PLoS One. .

Abstract

Objectives: To evaluate the epidemiological evolution of patients with HIV (PtHIV), between 2002 and 2012, in a day-hospital that became an HIV reference centre for south-west Burkina Faso.

Materials and methods: This was a retrospective study of PtHIV followed in the Bobo Dioulasso university hospital since 2002. The study was based on clinical data recorded using ESOPE software and analysed using Excel and SAS.

Results: A total of 7320 patients have been treated at the centre since 2002; the active file of patients increased from 147 in 2002 to 3684 patients in 2012. Mean age was stable at 38.4 years and the majority were female (71%). The delay to initiation of antiretroviral (ARV) treatment after HIV diagnosis decreased from 12.9 months in 2002 to 7.2 months in 2012. The percentage of PtHIV lost to follow-up, untreated for HIV and deaths all decreased after 2005. Voluntary anonymous screening and/or an evocative clinical picture were the main reasons for HIV diagnosis, usually at a late stage (41.1% at WHO stage 3). Virological success increased due to a decrease in time to initiation of ARV treatment and an increase in percentage of patients treated (90.5% in 2012, mainly with 1st line drugs). However, there was also a slight increase in the rate of therapeutic failures and the percentage of patients who progressed to 2nd or 3rd line-ARVs.

Conclusion: Our day-hospital is a good example of the implementation of a specialist centre for the management of PtHIV in a resource-limited country (Burkina Faso).

PubMed Disclaimer

Conflict of interest statement

Competing Interests: AH, AS, NFK have no conflicts of interest to disclose. JC has received consulting fees from Gilead (not related to this study). GP has received consulting or lecturing fees from Bristol-Myers Squibb, Boehringer Ingelheim, Tibotec, Nephrotek, Gilead, Roche, MSD, Abbott/Abbvie, ViiVHealthcare (not related to this study). CF has received lecturing fees from Abbott/Abbvie (not related to this study). LS has received personal fees from Bristol-Myers Squibb, Gilead, ViiVHealthcare (not related to this study). FXL has received consulting or lecturing fees from Bristol-Myers Squibb, Boehringer Ingelheim, Tibotec, Gilead, MSD, Abbott/Abbvie, ViiVHealthcare (not related to this study).

Figures

Fig 1
Fig 1. Socio-demographic characteristics of the study population.
Fig 2
Fig 2. Data for follow-up of HIV.
Fig 3
Fig 3. Survival probability curve among the HIV infected patients cohort at the Bobo-Dioulasso day hospital between 2002 and 2012.
Fig 4
Fig 4. Survival probability curve according to antiretroviral therapy among the HIV infected patients cohort at the Bobo-Dioulasso day hospital between 2002 and 2012.
(test de Breslow-Gehan-Wilcoxon P<10–4).
Fig 5
Fig 5. Clinico-biological data at HIV diagnosis.
Fig 6
Fig 6. Data for patients started on antiretroviral (ARV) treatment.
See this image and copyright information in PMC

References

    1. Global report: UNAIDS report on the global AIDS epidemic 2013. Available: http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiolo....
    1. Global AIDS Response Progress Reporting 2012, Burkina Faso. Available: http://www.unaids.org/en/dataanalysis/knowyourresponse/countryprogressre....
    1. Burkina Faso: Epidemiological fact sheets on HIV/AIDS and sexually transmitted disease; December 2006. WHO; Available: http://www.who.int/GlobalAtlas/predefinedReports/EFS2006/EFS_PDFs/EFS200....
    1. IeDea, Collaborations ARTC, Avila D, Althoff KN, Mugglin C, Wools-Kaloustian K, Koller M, Dabis F et al. Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries. J Acquir Immune Defic Syndr. 2014;65: e8–16. 10.1097/QAI.0b013e3182a39979 - DOI - PMC - PubMed
    1. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection [Internet] [cited 2013 Aug 16]. Available: http://www.who.int/hiv/pub/guidelines/arv2013/en/. - PubMed

Publication types

Substances